Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Keene

Showing results (111-120 of 353) with videos related to

Pageof 36
Sort By:
Parkinsonism & Related Disorders|July 2, 2022
Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutationsWilliam C Edelman, Kostantin Kiianitsa, Tuhin Virmani, et al.
Plos Genetics|July 29, 2024
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's diseaseSamuel N Smukowski, Cassidy Danyko, Jenna Somberg, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2023
Performance of a condensed protocol to assess limbic-predominant age-related TDP-43 encephalopathy neuropathologic changeHeather Maioli, Rhonda Mittenzwei, Jane B Shofer, et al.
Journal of Neuroscience Research|April 1, 2015
Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's diseaseErica J Melief, Eiron Cudaback, Nikolas L Jorstad, et al.
Acta Neuropathologica|December 6, 2008
A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesionsC Dirk Keene, Rubens C Chang, James B Leverenz, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2021
Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy CohortDouglas Barthold, Laura E Gibbons, Zachary A Marcum, et al.
The Journal of Clinical Investigation|March 28, 2020
Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model miceHelena R Zimmermann, Wenzhong Yang, Nicole P Kasica, et al.
Acta Neuropathologica|September 4, 2025
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's diseaseJordan Ogg, Nadia Postupna, Laura E Gibbons, et al.
Glycobiology|July 31, 2019
Quantitative analysis of chondroitin sulfate disaccharides from human and rodent fixed brain tissue by electrospray ionization-tandem mass spectrometryKimberly M Alonge, Aric F Logsdon, Taylor A Murphree, et al.
The American Journal of Pathology|April 25, 2009
Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2C Dirk Keene, Rubens Chang, Christina Stephen, et al.
Pageof 36

Showing results (111-120 of 353) with videos related to

Sort By:
Pageof 36
Parkinsonism & Related Disorders|July 2, 2022
Reduced gene dosage is a common mechanism of neuropathologies caused by ATP6AP2 splicing mutationsWilliam C Edelman, Kostantin Kiianitsa, Tuhin Virmani, et al.
Plos Genetics|July 29, 2024
mRNA and circRNA mislocalization to synapses are key features of Alzheimer's diseaseSamuel N Smukowski, Cassidy Danyko, Jenna Somberg, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2023
Performance of a condensed protocol to assess limbic-predominant age-related TDP-43 encephalopathy neuropathologic changeHeather Maioli, Rhonda Mittenzwei, Jane B Shofer, et al.
Journal of Neuroscience Research|April 1, 2015
Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's diseaseErica J Melief, Eiron Cudaback, Nikolas L Jorstad, et al.
Acta Neuropathologica|December 6, 2008
A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesionsC Dirk Keene, Rubens C Chang, James B Leverenz, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2021
Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy CohortDouglas Barthold, Laura E Gibbons, Zachary A Marcum, et al.
The Journal of Clinical Investigation|March 28, 2020
Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model miceHelena R Zimmermann, Wenzhong Yang, Nicole P Kasica, et al.
Acta Neuropathologica|September 4, 2025
Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's diseaseJordan Ogg, Nadia Postupna, Laura E Gibbons, et al.
Glycobiology|July 31, 2019
Quantitative analysis of chondroitin sulfate disaccharides from human and rodent fixed brain tissue by electrospray ionization-tandem mass spectrometryKimberly M Alonge, Aric F Logsdon, Taylor A Murphree, et al.
The American Journal of Pathology|April 25, 2009
Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2C Dirk Keene, Rubens Chang, Christina Stephen, et al.
Pageof 36